Susan A. Holechek, Ph.D.
Affiliations: | 2011 | Molecular and Cellular Biology | Arizona State University, Tempe, AZ, United States |
Area:
Virology Biology, Molecular Biology, ImmunologyGoogle:
"Susan Holechek"Parents
Sign in to add mentorBertram Jacobs | grad student | 2011 | Arizona State | |
(Lessons from Vaccinia Virus Post-Exposure Prophylaxis: Insights into Control of Diseases and Epidemics.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Moreno VM, Espinoza B, Bichara D, et al. (2017) Role of short-term dispersal on the dynamics of Zika virus in an extreme idealized environment. Infectious Disease Modelling. 2: 21-34 |
Franco LS, Holechek SA, Caplan MR, et al. (2017) Sequence-specific detection of different strains of LCMV in a single sample using tentacle probes. Virology Journal. 14: 197 |
Holechek SA, McAfee MS, Nieves LM, et al. (2016) Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination. Vaccine |
Holechek SA, Denzler KL, Heck MC, et al. (2013) Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses. Plos One. 8: e77879 |
Kibler KV, Gomez CE, Perdiguero B, et al. (2011) Improved NYVAC-based vaccine vectors. Plos One. 6: e25674 |
Denzler KL, Schriewer J, Parker S, et al. (2011) The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus. Vaccine. 29: 9691-6 |
Jacobs BL, Langland JO, Kibler KV, et al. (2009) Vaccinia virus vaccines: past, present and future. Antiviral Research. 84: 1-13 |
Jacobs B, Kibler K, Wong S, et al. (2009) OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines Retrovirology. 6 |